Ahead of the Budget, UK life sciences groups have called on the Chancellor to prioritise investment in new medicines.  The UK government has set out bold targets for the UK’s life sciences sector. By 2030, it wants the UK to lead Europe in commercial research and development (R&D) investment, scale-up finance and life sciences Foreign […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!